XAMOXA Trademark

Trademark Overview


On Wednesday, December 20, 2017, a trademark application was filed for XAMOXA with the United States Patent and Trademark Office. The USPTO has given the XAMOXA trademark a serial number of 87727736. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 12, 2021. This trademark is owned by Novartis AG. The XAMOXA trademark is filed in the Pharmaceutical Products category with the following description:

antivirals; cardiovascular pharmaceuticals; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney disease...
xamoxa

General Information


Serial Number87727736
Word MarkXAMOXA
Filing DateWednesday, December 20, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 12, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 10, 2018

Trademark Statements


Goods and Servicesantivirals; cardiovascular pharmaceuticals; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, January 6, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel 4002
CH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events


Event DateEvent Description
Monday, July 12, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 12, 2021ABANDONMENT - NO USE STATEMENT FILED
Saturday, December 12, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 11, 2020EXTENSION 5 GRANTED
Saturday, November 28, 2020EXTENSION 5 FILED
Thursday, December 10, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, November 28, 2020TEAS EXTENSION RECEIVED
Saturday, June 6, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 4, 2020EXTENSION 4 GRANTED
Thursday, June 4, 2020EXTENSION 4 FILED
Thursday, June 4, 2020TEAS EXTENSION RECEIVED
Thursday, December 5, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 3, 2019EXTENSION 3 GRANTED
Tuesday, December 3, 2019EXTENSION 3 FILED
Tuesday, December 3, 2019TEAS EXTENSION RECEIVED
Wednesday, June 5, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 3, 2019EXTENSION 2 GRANTED
Monday, June 3, 2019EXTENSION 2 FILED
Monday, June 3, 2019TEAS EXTENSION RECEIVED
Thursday, December 6, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 4, 2018EXTENSION 1 GRANTED
Tuesday, December 4, 2018EXTENSION 1 FILED
Tuesday, December 4, 2018TEAS EXTENSION RECEIVED
Tuesday, June 5, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 10, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 10, 2018PUBLISHED FOR OPPOSITION
Wednesday, March 21, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 2, 2018ASSIGNED TO LIE
Wednesday, February 21, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 20, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 20, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 20, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 24, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 24, 2018NON-FINAL ACTION E-MAILED
Wednesday, January 24, 2018NON-FINAL ACTION WRITTEN
Friday, January 19, 2018ASSIGNED TO EXAMINER
Saturday, January 6, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, December 23, 2017NEW APPLICATION ENTERED IN TRAM